Caladrius_Logo_March_2017.png
Caladrius Biosciences to Present at American Heart Association’s Virtual Scientific Sessions 2020
November 10, 2020 08:30 ET | Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
Caladrius_Logo_March_2017.png
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
November 05, 2020 16:05 ET | Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
Caladrius_Logo_March_2017.png
Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in November
November 04, 2020 08:30 ET | Caladrius Biosciences, Inc.
BASKING RIDGE, N.J. , Nov. 04, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
Caladrius_Logo_March_2017.png
Caladrius Biosciences Appoints Industry Veteran, Anne Whitaker, to Board of Directors
November 02, 2020 08:30 ET | Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
Caladrius_Logo_March_2017.png
Caladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time
October 29, 2020 08:30 ET | Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
Caladrius_Logo_March_2017.png
Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360°
October 21, 2020 08:30 ET | Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
Caladrius_Logo_March_2017.png
Caladrius Biosciences Opens Study of CLBS119 to Repair COVID-19-Induced Lung Damage
October 08, 2020 08:00 ET | Caladrius Biosciences, Inc.
Patient screening begins immediately at NYU Langone Health The study will explore the ability of CLBS119 to restore normal oxygen levels in patients who have recovered from the virus but require...
Caladrius_Logo_March_2017.png
Caladrius Biosciences to Present at the Alliance for Regenerative Medicine’s Virtual Cell and Gene Meeting on the Mesa
October 07, 2020 16:05 ET | Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
Caladrius_Logo_March_2017.png
Caladrius Biosciences to Present at the BIO Investor Forum Digital
October 06, 2020 16:05 ET | Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...
Caladrius_Logo_March_2017.png
Caladrius Biosciences to Participate in Landmark’s 10th Annual Investing for Cures Virtual Forum
September 10, 2020 08:00 ET | Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the...